FDA Approved: FINTEPLA — Supplemental Application (UCB, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Fintepla (fenfluramine) by UCB, Inc. The action updates the product’s labeling as part of the supplemental submi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Fintepla (Fenfluramine)

Snippet

SUPPL AP for FINTEPLA (FENFLURAMINE)